CHARLES RIVER LABORATORIES INTL. news, videos and press releases
For more news please use our advanced search feature.
CHARLES RIVER LABORATORIES INTL. - More news...
CHARLES RIVER LABORATORIES INTL. - More news...
- Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform
- Charles River Laboratories to Present at Barclays Global Healthcare Conference
- Charles River Announces Agreement with Singapore General Hospital
- Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance
- Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions
- Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call
- Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences
- Charles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy Platform
- Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
- Charles River Introduces Global Biotech Incubator Program
- Charles River Laboratories to Present at Evercore ISI Investor Conference
- Charles River Laboratories to Present at UBS and Jefferies Conferences
- Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
- Charles River Laboratories Announces Second-Quarter 2023 Results
- Charles River Laboratories Expands Access to AAALAC-Accredited, Turnkey Research Space in Key Markets
- Charles River Laboratories Schedules Second-Quarter 2023 Earnings Release and Conference Call
- IMPORTANT JULY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm
- SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm
- SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm
- Charles River Laboratories Launches Off-the-Shelf Lentiviral Vector Packaging Plasmids
- Charles River and Curigin Collaborate to Produce Oncolytic RNAi Gene Therapy
- Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration
- Charles River Laboratories to Present at William Blair and Jefferies Conferences
- Charles River Laboratories and Wheeler Bio Announce Agreement to Build and Operate RightSourceSM Laboratory
- SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm
- INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm
- Charles River Laboratories Announces First-Quarter 2023 Results
- Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID
- Charles River Laboratories Schedules First-Quarter 2023 Earnings Release and Conference Call
- Charles River Laboratories Showcases End-to-End Oncology Capabilities at AACR 2023
